TEMAZEPAM-D5
- CAS No.
- 136765-51-0
- Chemical Name:
- TEMAZEPAM-D5
- Synonyms
- TEMAZEPAM-D5;Temazepam-d5 (CRM);Temazepam-d5 solution;Temazepam-d5 (phenyl-d5);TEMAZEPAM-D5,100/MLINMETHANOL;[2H5]-Temazepam, racemic mixture;Temazepam-D5, 1mg/ml in Methanol;Temazepam-D5 1.0 mg/ml in Methanol;Temazepam-D5 0.1 mg/ml in Methanol;TEMAZEPAM (D5, 98%) 100 UG/ML IN METHANOL
- CBNumber:
- CB7768435
- Molecular Formula:
- C16H8ClD5N2O2
- Molecular Weight:
- 305.77
- MDL Number:
- MFCD00673311
- MOL File:
- 136765-51-0.mol
- MSDS File:
- SDS
| Boiling point | 549.874±50.00 °C(Press: 760.00 Torr)(predicted) |
|---|---|
| Density | 1.348±0.14 g/cm3(Temp: 25 °C; Press: 760 Torr)(predicted) |
| Flash point | 9℃ |
| storage temp. | -20°C |
| pka | 11.664±0.40(predicted) |
| InChIKey | SEQDDYPDSLOBDC-VIQYUKPQSA-N |
| FDA UNII | K28RMB8E9D |
| EPA Substance Registry System | 2H-1,4-Benzodiazepin-2-one, 7-chloro-1,3-dihydro-3-hydroxy-1-methyl-5-(phenyl-d5)- (136765-51-0) |
SAFETY
Risk and Safety Statements
| Symbol(GHS) |    GHS02,GHS06,GHS08 |
|||||||||
|---|---|---|---|---|---|---|---|---|---|---|
| Signal word | Danger | |||||||||
| Hazard statements | H225-H301+H311+H331-H370 | |||||||||
| Precautionary statements | P210-P260-P280-P301+P310-P311 | |||||||||
| Hazard Codes | F,T | |||||||||
| Risk Statements | 11-23/24/25-39/23/24/25 | |||||||||
| Safety Statements | 7-16-36/37-45 | |||||||||
| RIDADR | UN1230 - class 3 - PG 2 - Methanol, solution | |||||||||
| WGK Germany | 1 | |||||||||
| NFPA 704 |
|
TEMAZEPAM-D5 price More Price(12)
| Manufacturer | Product number | Product description | CAS number | Packaging | Price | Updated | Buy |
|---|---|---|---|---|---|---|---|
| Sigma-Aldrich | T-912 | Temazepam-d5 solution 1.0?mg/mL in methanol, ampule of 1?mL, certified reference material, Cerilliant? | 136765-51-0 | 1mL | $190 | 2026-04-30 | Buy |
| Sigma-Aldrich | T-902 | Temazepam-d5 solution 100?μg/mL in methanol, ampule of 1?mL, certified reference material, Cerilliant? | 136765-51-0 | 1mL | $49.1 | 2026-04-30 | Buy |
| Cayman Chemical | 15859 | Temazepam-d5 ≥98% | 136765-51-0 | 500μg | $69 | 2026-04-30 | Buy |
| Cayman Chemical | 18565 | Temazepam-d5 (CRM) | 136765-51-0 | 1mg | $135 | 2026-04-30 | Buy |
| Cayman Chemical | 15859 | Temazepam-d5 ≥98% | 136765-51-0 | 1mg | $127 | 2026-04-30 | Buy |
TEMAZEPAM-D5 Chemical Properties,Uses,Production
Description
Temazepam-d5 (Item No. 15859) is an analytical reference material intended for use as an internal standard for the quantification of temazepam . Temazepam is categorized as a benzodiazepine. Temazepam has sedative-hypnotic properties and misuse via intra-arterial injection has been associated with tissue damage and subsequent amputation. Temazepam-d5 is regulated as a Schedule IV compound in the United States. This product is intended for research and forensic applications.
Uses
Temazepam (Phenyl D5) is labelled Temazepam (T017200) which is an intermediate-acting 3-hydroxy hypnotic of the benzodiazepine class of psychoactive drugs. Temazepam has anxiolytic (anti-anxiety), anticonvulsant, and skeletal muscle relaxant properties.
References
[1] SHANLIN FU. Reduction of temazepam to diazepam and lorazepam to delorazepam during enzymatic hydrolysis[J]. Analytical and Bioanalytical Chemistry, 2011, 400 1: 153-164. DOI: 10.1007/s00216-011-4723-y
[2] D.M. NOTT . Intra-arterial injection of temazepam in drug abusers[J]. European journal of vascular surgery, 1993, 7 1: Pages 87-89. DOI: 10.1016/s0950-821x(05)80550-x
[3] GERALD FX FEENEY MB BCH BAO FRACP Harry H G M B F. Digit loss following misuse of temazepam[J]. Medical Journal of Australia, 2002, 176 8: 380. DOI: 10.5694/j.1326-5377.2002.tb04460.x
